Volume 10, Issue 2, Pages (February 2018)

Slides:



Advertisements
Similar presentations
Volume 9, Issue 5, Pages (November 2017)
Advertisements

Constitutively Active β-Catenin Confers Multilineage Differentiation Potential on Lymphoid and Myeloid Progenitors  Yoshihiro Baba, Karla P. Garrett,
Volume 13, Issue 2, Pages (August 2013)
Volume 17, Issue 1, Pages (July 2015)
Volume 25, Issue 9, Pages (September 2017)
Myung Jin Son, Kevin Woolard, Do-Hyun Nam, Jeongwu Lee, Howard A. Fine 
Volume 8, Issue 5, Pages (May 2017)
Volume 22, Issue 5, Pages (January 2018)
Francesca Ficara, Mark J. Murphy, Min Lin, Michael L. Cleary 
Acute myeloid leukemia xenograft success prediction: Saving time
Volume 4, Issue 4, Pages (August 2013)
Volume 2, Issue 6, Pages (June 2014)
Volume 11, Issue 12, Pages (June 2015)
Volume 20, Issue 12, Pages (September 2017)
Volume 14, Issue 12, Pages (March 2016)
Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α
Volume 3, Issue 5, Pages (November 2014)
Volume 1, Issue 2, Pages (August 2013)
Volume 2, Issue 6, Pages (June 2014)
Volume 17, Issue 10, Pages (December 2016)
Adult Mouse Liver Contains Two Distinct Populations of Cholangiocytes
Volume 7, Issue 4, Pages (October 2016)
Volume 7, Issue 5, Pages (November 2016)
Qiuping He, Suwei Gao, Junhua Lv, Wei Li, Feng Liu 
Volume 4, Issue 2, Pages (February 2003)
Volume 25, Issue 9, Pages (September 2017)
Volume 9, Issue 5, Pages (November 2017)
Volume 4, Issue 2, Pages (February 2015)
Volume 22, Issue 5, Pages (January 2018)
Volume 10, Issue 5, Pages (November 2004)
Clinically Relevant Expansion of Hematopoietic Stem Cells with Conserved Function in a Single-Use, Closed-System Bioprocess  Gerard J. Madlambayan, Ian.
Volume 8, Issue 3, Pages (March 2017)
Volume 2, Issue 6, Pages (December 2012)
Volume 5, Issue 4, Pages (October 2015)
Volume 4, Issue 3, Pages (March 2015)
Kenichi Miharada, Valgardur Sigurdsson, Stefan Karlsson  Cell Reports 
Volume 4, Issue 3, Pages (March 2015)
Volume 41, Issue 2, Pages (August 2014)
Volume 10, Issue 5, Pages (May 2018)
Volume 8, Issue 2, Pages (February 2011)
Volume 8, Issue 4, Pages (April 2017)
Volume 43, Issue 2, Pages (August 2015)
Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells
Volume 6, Issue 2, Pages (February 2016)
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 9, Issue 1, Pages (July 2011)
Volume 6, Issue 3, Pages (March 2016)
Volume 10, Issue 3, Pages (March 2018)
Volume 1, Issue 6, Pages (December 2013)
Volume 9, Issue 5, Pages (November 2017)
Volume 10, Issue 6, Pages (December 2004)
Volume 2, Issue 1, Pages (January 2014)
Volume 9, Issue 1, Pages 5-11 (July 2017)
Volume 11, Issue 3, Pages (September 2012)
Volume 16, Issue 12, Pages (September 2016)
Masayuki Yamashita, Eriko Nitta, Toshio Suda  Cell Stem Cell 
Volume 22, Issue 5, Pages (January 2018)
Volume 10, Issue 4, Pages (April 2018)
Xuepei Lei, Jianwei Jiao  Stem Cell Reports 
Volume 16, Issue 1, Pages (January 2015)
Volume 6, Issue 5, Pages (May 2016)
Volume 10, Issue 3, Pages (March 2018)
Kiran Batta, Magdalena Florkowska, Valerie Kouskoff, Georges Lacaud 
Volume 8, Issue 1, Pages (January 2011)
Volume 3, Issue 6, Pages (December 2014)
Volume 11, Issue 5, Pages (November 2018)
Volume 23, Issue 8, Pages (May 2018)
Volume 17, Issue 4, Pages (October 2015)
Volume 2, Issue 3, Pages (March 2008)
Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture  Yi Arial Zeng, Roel Nusse  Cell Stem Cell 
Presentation transcript:

Volume 10, Issue 2, Pages 436-446 (February 2018) Transcriptionally and Functionally Distinct Mesenchymal Subpopulations Are Generated from Human Pluripotent Stem Cells  Chee Jia Chin, Suwen Li, Mirko Corselli, David Casero, Yuhua Zhu, Chong Bin He, Reef Hardy, Bruno Péault, Gay M. Crooks  Stem Cell Reports  Volume 10, Issue 2, Pages 436-446 (February 2018) DOI: 10.1016/j.stemcr.2017.12.005 Copyright © 2017 The Author(s) Terms and Conditions

Figure 1 Immunophenotypic Fractionation of hPSC-Derived Mesenchyme Reveals Transcriptionally Distinct Populations (A) hEMPs were generated from hPSC and isolated at day 3.5 by FACS for further differentiation in mesenchymal conditions. After 2 weeks, two distinct populations were identified within the CD31− (non-endothelial) cells, which were also CD45− (non-hematopoietic, not shown). CD146loCD73lo cells (red) were CD140a+, and CD146hiCD73hi cells (blue) were CD140lo or CD140a− (representative data using H1 cells of n = 16 experiments). (B) Cell-cycle analysis of hEMP-derived mesenchymal differentiation cultures at week 2, pulsed with bromodeoxyuridine (BrdU) for 40 min, and gated on CD31− mesenchyme, as shown in Figure 1A, as either “CD146hiCD73hi” or “CD146loCD73lo.” n = 3 biological replicates. The y axis shows the percentage of each mesenchymal phenotype in each stage of cell cycle, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. (C) Selected genes from RNA-seq profiling of hEMP, and hEMP-derived CD146hiCD73hi and CD146loCD73lo mesenchyme (as in Figure 1A). Relative expression shown for each gene using its min/max moderate expression estimates as reference. n = 3 biological replicates. Error bars represent SEM. See also Figures S1 and S2. Stem Cell Reports 2018 10, 436-446DOI: (10.1016/j.stemcr.2017.12.005) Copyright © 2017 The Author(s) Terms and Conditions

Figure 2 CD146hiCD73hi Mesenchyme Supports Ex Vivo Maintenance of Clonogenic, Engraftable, and Self-Renewing HSPCs CD146hiCD73hi and CD146loCD73lo mesenchymal cells generated from H1-derived hEMP were isolated and co-cultured as monolayers with CB CD34+ cells in 5% serum without added cytokines. After 2 weeks, hematopoietic cells were assayed (A–G) in vitro and (H–J) in vivo. (A) Total number of live (DAPI–) CD45+ cells recovered from co-cultures, shown as cell yield normalized to 1,000 input CD34+ cells. (B) Representative FACS analysis of CD45+ gated cells from co-cultures. (C–G) Cell yield of CD34+, CD34+ Lin−, CD14+ myeloid, CD10+/CD19+ B lymphoid cells, and CFU (after re-plating) recovered from 2-week CD146hiCD73hi co-cultures, normalized to CD146loCD73lo co-cultures. (A and C–G) n = 16 independent experiments, each in duplicate. Shown are mean ± SEM. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗∗p < 0.0001; unpaired two-tailed Student's t test. (H) Flow cytometry showing gating for the detection of human cells (hCD45+HLA ABC+) and multi-lineage reconstitution after primary transplant. PBS control with no cells injected. (I) Proportion of mice with engraftment, i.e., detection of >1% human cells after primary transplant (1°) with 1 × 105 CD45+ cells obtained either from fresh CB CD34+ cells (CB w/o culture), or 2 weeks after co-culture on CD146hiCD73hi or CD146loCD73lo. (J) Engraftment (percent of human cells) of mice 6 weeks after primary and secondary transplants (n = 5 independent experiments, total 9–14 mice per group; ∗∗∗p <.0001; ns, not significant). Error bars represent SEM. See also Figure S3. Stem Cell Reports 2018 10, 436-446DOI: (10.1016/j.stemcr.2017.12.005) Copyright © 2017 The Author(s) Terms and Conditions

Figure 3 Notch Inhibition and Activation of Wnt Signaling in hPSC-Mesenchyme Co-cultures Leads to Loss of HSPC (A) Shown is relative number of CD34+Lin− cells in contact and transwell co-culture normalized to yield from CD146loCD73lo transwell co-cultures (n = 3 independent experiments, mean ± SEM. ∗p < 0.05). (B) qRT-PCR of JAG1 in CD146hiCD73hi and CD146loCD73lo mesenchyme (n = 14 biological replicates, ∗∗p < 0.01). (C) qRT-PCR of HES1 in CD34+ cells recovered from CD146hiCD73hi and CD146loCD73lo mesenchyme after 7 days of co-culture without extra cytokines (n = 5 biological replicates, p = 0.1789). (D) Number of CD34+ Lin− cells harvested from hPSC-mesenchyme after co-culture in the presence of human JAG1 blocking antibody or control goat IgG (∗p < 0.05, ∗∗p < 0.01, n = 3 independent experiments). (E) Expression of WNT inhibitors SFRP1, SFRP2, and DKK1 in CD146hiCD73hi and CD146loCD73lo mesenchyme (n = 3 biological replicates, RNA-seq ∗∗FDR < 0.01, ∗∗∗FDR < 0.001). (F) qRT-PCR of WNT target genes TCF7 and LEF1 in Lin+ cells recovered from CD146hiCD73hi and CD146loCD73lo mesenchyme after 7 days of co-culture without extra cytokines (n = 5 biological replicates, ∗p < 0.05). (G) CD34+ Lin−, myeloid and lymphoid cell numbers after activation of Wnt signaling by addition of 3 μM CHIR99021 (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001; ns, not significant; n = 3 independent experiments). Error bars represent SEM. See also Figure S4. Stem Cell Reports 2018 10, 436-446DOI: (10.1016/j.stemcr.2017.12.005) Copyright © 2017 The Author(s) Terms and Conditions

Figure 4 hPSC-Derived CD146hiCD73hi Mesenchyme Shares a Molecular Signature with Primary Human Adult Pericytes (A and B) Gene set enrichment analysis of hPSC-derived mesenchyme and lipoaspirate-derived populations (both freshly sorted and cultured). (A) Positive and (B) negative signatures were defined, respectively, as up- and downregulated genes in hPSC-derived CD146hiCD73hi compared with hPSC-derived CD146loCD73lo cells. The x axis represents genes ranked from positive to negative fold change in lipoaspirate-CD146+ compared with lipoaspirate-CD146− cells. Genes in the core enrichment set are highlighted (shaded gray boxes) and selected genes in this core enrichment set are shown. (C) Up- and downregulated genes common to the core sets of CD146hi from hPSC and fresh and cultured primary CD146+ cells were imported into the STRING database, which identified a network of known protein-protein interactions (enrichment p value = 0), along with a number of high-confidence (score > 0.9999) predicted interactions. Line thickness is proportional to the confidence level of each interaction. See also Table S1. Stem Cell Reports 2018 10, 436-446DOI: (10.1016/j.stemcr.2017.12.005) Copyright © 2017 The Author(s) Terms and Conditions